Supernus Pharma Balance Sheet - Quarterly (NASDAQ:SUPN)

Add to My Stocks
$54.25 $0.45 (0.82%) SUPN stock closing price Jul 19, 2018 (Closing)

A balance sheet is one of the three key financial statements released by a publicly listed company like Supernus Pharma, and helps in stock analysis. Balance sheet items like cash at hand, total assets and liabilities helps one analyze a company and summarize the financial performance of the company like we have in our Supernus Pharma stock analysis. A company releases its balance sheet every quarter along with its quarterly results. Apart from analyzing Supernus Pharma revenue Supernus Pharma operating cash flow, one needs to check balance sheet items like cash, fixed assets and debt. The Supernus Pharma balance sheet for 2018 Q1 shows cash on hand of $444.14M. The company has a debt to equity ratio of 0.9.

View and download Supernus Pharma quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Marketable Securities45.58M39.73M32.62M31.22M27.53M23.72M26.02M24.05M25.42M28.03M
Raw Materials1.77M2.99M2.17M2.97M4.3M2.09M2.78M2.93M2.37M2.88M
Work In Progress10M8.87M4.69M8.64M9.39M8.87M8.11M6.23M4.26M3.94M
Finished Goods7.29M4.43M8.07M5M5.46M5.83M6.55M7.2M6.4M5.75M
Notes Receivable----------
Other Current Assets6.58M6.52M5.66M4.74M4.57M2.95M4.2M3.27M5M5.29M
Total Current Assets
Property Plant & Equipment14.76M14.47M13.71M13.29M12.74M12.44M12.14M11.74M11.12M10.84M
Accumulated Depreciation9.76M9.34M9.02M8.72M8.39M8.09M7.82M7.55M7.25M6.96M
Net Property Plant & Equipment
Investment & Advances175.06M133.63M123.12M104.63M89.16M75.41M67.04M67.8M68.79M55M
Other Non-Current Assets----------
Deferred Charges26.25M20.84M28.8M42.33M49.19M61.58M59.69M16.38M11.44M22.5M
Deposits & Other Assets----------
Total Assets
Notes Payable-----11.8M6.77M---
Accounts Payable3.33M6.84M6.26M7.57M5.05M8.05M2.68M2.24M2.64M4.31M
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses114.32M111.58M93.15M72.66M72.01M69.37M66.41M63.12M51.27M51.6M
Income Taxes Payable----------
Other Current Liabilities1.43M4.57M5.54M5.28M4.93M3.31M2.54M---
Total Current Liabilities
Deferred Taxes/Income-1.14M1.22M1.29M1.36M1.5M1.55M1.6M1.65M1.39M
Convertible Debt318.22M--1.47M3.31M4.16M5.77M5.69M5.62M7.18M
Long-Term Debt----------
Non-Current Capital Leases----------
Other Long-Term Liabilities35.97M32.83M27.63M28.68M29.51M31.4M32.77M4.73M34.54M5.17M
Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus352.25M294.99M291.84M285.57M279.79M276.12M271.8M270.05M267.57M263.95M
Retained Earnings1.85M-26.82M-40.48M-56.44M-73.81M-84.28M-98.6M-129.63M-139.65M-144.64M
Treasury Stock----------
Other Liabilities-2.29M-0.74M----0.13M----0.48M
Shareholders Equity351.86M267.48M251.66M229.39M206.06M191.75M173.37M141.02M128.13M118.87M
Total Liabilities & Shareholders Equity825.16M424.46M385.47M346.37M322.25M309.56M285.11M218.63M194.47M188.73M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Looking at Supernus Pharma historical stock prices and the current Supernus Pharma stock price can tell you how the stock price has moved, whereas the Supernus Pharma PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: An asset is a resource that a corporation like Supernus Pharma owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for SUPN stock as of 2018 Q1 is $825.16M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities: This item on the balance sheet implies the firm's, in this case Supernus Pharma's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for SUPN stock stand at $473.29M.

Supernus Pharma Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover
Price to book ratio